Synchroneuron Inc. logo

Synchroneuron Inc.

Synchroneuron Inc., a biopharmaceutical company, develops therapies for tardive dyskinesia and other neuropsychiatric disorders. It offers SNC-102, a new formulation of acamprosate calcium that improves pharmacokinetic properties over the marketed formulation.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://synchroneuron.com
Founded2011
Disease Focus
Development Stage
STOCK CODENon Listed
Address
130 Tobey Garden Street, MA 02332
Duxbury
United States
Email
Contact Number
+1 617-538-5688

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/synchroneuron-inc.” connections=”true” suffix=””]